olmesartan medoxomilo + hidroclorotiazida azevedos 20 mg + 12.5 mg comprimido revestido por película
laboratórios azevedos - indústria farmacêutica, s.a. - olmesartan medoxomilo + hidroclorotiazida - comprimido revestido por película - 20 mg + 12.5 mg - hidroclorotiazida 12.5 mg ; olmesartan medoxomilo 20 mg - olmesartan medoxomil and diuretics - genérico - duração do tratamento: longa duração
olmesartan medoxomilo + hidroclorotiazida azevedos 40 mg + 25 mg comprimido revestido por película
laboratórios azevedos - indústria farmacêutica, s.a. - olmesartan medoxomilo + hidroclorotiazida - comprimido revestido por película - 40 mg + 25 mg - hidroclorotiazida 25 mg ; olmesartan medoxomilo 40 mg - olmesartan medoxomil and diuretics - genérico - duração do tratamento: longa duração
tremfya
janssen-cilag international nv - guselkumab - psoríase - imunossupressores - plaque psoriasis tremfya is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritis tremfya, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adult patients who have had an inadequate response or who have been intolerant to a prior disease-modifying antirheumatic drug (dmard) therapy (see section 5.
empliciti
bristol-myers squibb farmacÊutica ltda - elotuzumabe - antineoplasico
veklury
gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.
regkirona
celltrion healthcare hungary kft. - regdanvimab - covid-19 virus infection - imune soros e imunoglobulinas, - regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (covid-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.
xevudy
glaxosmithkline trading services limited - sotrovimab - covid-19 virus infection - imune soros e imunoglobulinas, - xevudy is indicated for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (covid-19) who do not require oxygen supplementation and who are at increased risk of progressing to severe covid-19.
anaquetan xr 200 mg comprimido de libertação prolongada
anabiosis pc - quetiapina - comprimido de libertação prolongada - 200 mg - quetiapina, fumarato 230.3 mg - quetiapine - genérico - duração do tratamento: longa duração
anaquetan xr 200 mg comprimido de libertação prolongada
anabiosis pc - quetiapina - comprimido de libertação prolongada - 200 mg - quetiapina, fumarato 230.3 mg - quetiapine - genérico - duração do tratamento: longa duração
anaquetan xr 50 mg comprimido de libertação prolongada
anabiosis pc - quetiapina - comprimido de libertação prolongada - 50 mg - quetiapina, fumarato 57.575 mg - quetiapine - genérico - duração do tratamento: longa duração